Statement: Potential participants will be considered regardless of the hormone receptivity of their breast cancer, except if they are overexpressing ERBB2.
Primary_evidence: Inclusion Criteria:   English speaking   Diagnosis of stage 1-3 histologically confirmed first cancer of the breast   Reside in a zip code designated as rural by the United States Department of Agriculture Economic Research Service   Be within the initial 12 months following the end of primary treatment and meet 3 of the following 5 criteria for MetS confirmed via point-of-care testing or documentation in their medical record:   A large waistline > 35 inches Blood pressure > 130/85; HbA1c of 5.7%-6.4%; Triglyceride levels > 150 mg/dL; HDL cholesterol levels < 50 mg/dL Exclusion Criteria:   Will not exclude participants based on hormone receptivity, one exception is that we will exclude HER2 positive BCS   Pregnant patients   Resistant Hypertension   Steroid-dependent asthma or Chronic obstructive pulmonary disease   Cirrhosis or hepatic failure   A major cardiovascular event (e.g., stroke, myocardial infarction) within the previous 90 days   Chronic kidney disease on renal replacement therapy   Type one or two diabetes   Stage 4 cancer; those with a secondary cancer (except for nonmelanomatous skin cancers and carcinoma of the cervix in situ)   Taking weight loss medications   Current involvement in a behavioral program   Neuropsychiatric disorder or dementia